- Home
- PAVS vs TLSA Comparison
PAVS vs TLSA Comparison
Compare PAVS & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- TLSA
- Stock Information
- Founded
- PAVS 2004
- TLSA 2013
- Country
- PAVS United States
- TLSA United Kingdom
- Employees
- PAVS N/A
- TLSA N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- PAVS Health Care
- TLSA Health Care
- Exchange
- PAVS Nasdaq
- TLSA Nasdaq
- Market Cap
- PAVS 89.6M
- TLSA 187.0M
- IPO Year
- PAVS 2019
- TLSA 2000
- Fundamental
- Price
- PAVS $0.92
- TLSA $1.48
- Analyst Decision
- PAVS
- TLSA
- Analyst Count
- PAVS 0
- TLSA 0
- Target Price
- PAVS N/A
- TLSA N/A
- AVG Volume (30 Days)
- PAVS 5.0K
- TLSA 242.1K
- Earning Date
- PAVS 07-31-2025
- TLSA 07-22-2025
- Dividend Yield
- PAVS N/A
- TLSA N/A
- EPS Growth
- PAVS N/A
- TLSA N/A
- EPS
- PAVS N/A
- TLSA N/A
- Revenue
- PAVS $6,613,273.00
- TLSA N/A
- Revenue This Year
- PAVS N/A
- TLSA N/A
- Revenue Next Year
- PAVS N/A
- TLSA N/A
- P/E Ratio
- PAVS N/A
- TLSA N/A
- Revenue Growth
- PAVS 2.50
- TLSA N/A
- 52 Week Low
- PAVS $0.32
- TLSA $0.63
- 52 Week High
- PAVS $1.50
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- PAVS 54.80
- TLSA 47.20
- Support Level
- PAVS $0.82
- TLSA $1.43
- Resistance Level
- PAVS $0.98
- TLSA $1.81
- Average True Range (ATR)
- PAVS 0.04
- TLSA 0.09
- MACD
- PAVS 0.02
- TLSA -0.02
- Stochastic Oscillator
- PAVS 79.76
- TLSA 13.16
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.